Article info
PDFCoronary artery disease
Original article
Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction
- Correspondence to Dr Bernhard Metzler, University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria; Bernhard.Metzler{at}tirol-kliniken.at
Citation
Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction
Publication history
- Received August 25, 2016
- Revised November 4, 2016
- Accepted November 8, 2016
- First published December 15, 2016.
Online issue publication
January 18, 2021
Article Versions
- Previous version (10 May 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/